New York man sues MRI firm over missed stroke risk

A New York man has filed a lawsuit against Prenuvo, claiming its $2,500 whole-body MRI scan failed to detect a critical artery narrowing that led to his massive stroke months later. Sean Clifford argues that early intervention could have prevented his severe disabilities. The case highlights ongoing debates about the reliability of elective full-body scans.

Sean Clifford underwent a whole-body MRI scan at Prenuvo on July 15, 2023, costing $2,500. The imaging revealed a 60 percent narrowing and irregularity in the proximal right middle cerebral artery, a key vessel often linked to strokes. However, Prenuvo's report stated that his brain appeared normal, with no adverse findings flagged.

Nearly eight months later, on March 7, 2024, Clifford suffered a devastating stroke when the artery became fully blocked. The incident left him with paralysis in his left hand and leg, weakness on his left side, permanent vision loss including double vision, and challenges including anxiety, depression, mood swings, cognitive issues, speech difficulties, and struggles with daily activities.

In September 2024, Clifford sued Prenuvo in New York State Supreme Court, asserting that awareness of the issue could have prompted stenting or other preventive measures. Prenuvo, based in California and backed by figures like Kim Kardashian, Cindy Crawford, and Anne Wojcicki, attempted to enforce arbitration and apply California's damage caps, but a judge rejected both motions in December. The court also refused to protect the reviewing radiologist, William A. Weiner, whose medical license was suspended over falsified MRI reports in an insurance fraud case.

Clifford's lawyer, Neal Bhushan, welcomed the ruling: “I am pleased that the court sided with us. This ruling reaffirms the strength and merits of our medical malpractice and negligence claims, and we look forward to continuing to litigate this matter in New York County Supreme Court.” Prenuvo responded: “We take any allegation seriously and are committed to addressing it through the appropriate legal process. Our focus remains on delivering safe, high quality, proactive care to the patients who place their trust in us every day.”

The lawsuit underscores broader concerns about elective whole-body MRIs, which are not insurance-covered and lack endorsement from bodies like the American College of Radiology. Critics argue these scans often yield insignificant findings, prompting unnecessary tests and exacerbating healthcare inequities, while potentially overlooking serious issues in non-targeted reviews.

Labaran da ke da alaƙa

Illustration of heart risk tools failing to detect hidden arterial plaque in a patient, highlighting study findings on screening limitations.
Hoton da AI ya samar

Study: Heart-attack risk tools fail to flag nearly half of future patients

An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya

A Mount Sinai–led study finds that commonly used heart-attack risk calculators and symptom-based screening fail to identify nearly half of people who will soon experience a first heart attack. The brief report, published November 21 in JACC: Advances, underscores limitations in current prevention strategies and argues for earlier imaging to detect silent plaque.

Researchers have developed a non-invasive imaging tool called fast-RSOM that visualizes the body's smallest blood vessels through the skin. This technology identifies early microvascular endothelial dysfunction, a precursor to cardiovascular disease, allowing for earlier interventions. The portable device could integrate into routine checkups to improve heart health outcomes.

An Ruwaito ta hanyar AI

A 22-year-old woman has secured a $2 million malpractice judgment against two medical providers who performed a double mastectomy on her at age 16. The jury ruled that the doctors failed to properly assess her mental health before approving the irreversible surgery. This verdict is poised to influence broader discussions on gender-affirming care.

Chinese biotech firm SciNeuro Pharmaceuticals has partnered with Swiss pharmaceutical giant Novartis in a deal worth nearly $1.7 billion to develop treatments for Alzheimer's disease, which affects some 55 million people worldwide. The agreement grants Novartis exclusive worldwide rights to develop and commercialise SciNeuro's antibody candidates for the progressive brain disease. SciNeuro's novel amyloid beta-targeted antibody programme leverages proprietary blood-brain barrier shuttle technology to help more of the drug cross into the brain where Alzheimer's damage occurs.

An Ruwaito ta hanyar AI An Binciki Gaskiya

Researchers have developed a deep learning model that estimates chronic stress burden by measuring adrenal gland volume on standard CT scans, introducing what they describe as the first imaging-based biomarker for chronic stress. The metric, called the Adrenal Volume Index, is linked to cortisol exposure, perceived stress, overall physiological stress load and long-term cardiovascular risk, according to findings to be presented at the Radiological Society of North America's annual meeting.

Actor Henri Castelli, 47, suffered two convulsions in under seven hours during the leader's proof on Big Brother Brazil 26, on Wednesday, January 14, 2026. After hospitalization and release, he had another episode upon returning to the house, leading to his removal from the show and criticism of Globo's production.

An Ruwaito ta hanyar AI

Chile's National Consumer Service (Sernac) has issued a formal request to Clínica Dávila following a cyberattack that leaked about 250 gigabytes of sensitive patient data. The agency demands detailed information within 10 business days on the incident, attributed to a foreign ransomware group named Devman. Compromised data includes clinical records, diagnoses, and medical test results, such as HIV screenings.

 

 

 

Wannan shafin yana amfani da cookies

Muna amfani da cookies don nazari don inganta shafin mu. Karanta manufar sirri mu don ƙarin bayani.
Ƙi